Onze website maakt gebruik van cookies voor een optimale gebruikerservaring. Wilt u de website bezoeken en cookies accepteren? Lees hier ons cookiebeleid
Ravi F.M. Vermeulen, Jesse L. van Altena, Katja N. Gaarenstroom, Marc van Beurden, Jacobien K. Kieffer, Neil K. Aaronson, Gemma G. Kenter, Catharina M. Korse. Impact of risk-reducing salpingo-oophorectomy on lipid determinants, HbA1c, and CRP. Climacteric. 2023 Oct;26(5):489-496.
Ravi F.M. Vermeulen*, Lennart J. van Winden*, Vincent van den Noort, Katja N. Gaarenstroom, Gemma G. Kenter, Monique M.A. Brood-van Zanten, Catharina M. Korse, Marc van Beurden#, Huub H. van Rossum# *Authors share first authorship position # Authors share last authorship position. Changes in sex steroids and relation with menopausal complaints in women undergoing risk-reducing salpingo-oophorectomy. J Endocr Soc. 2022 Apr 25;6(6):bvac069.
Feline O. Voss, Nikki B. Thuijs, Ravi F.M. Vermeulen, Erica A. Wilthagen, Marc van Beurden, Maaike C.G. Bleeker. The Vulvar Cancer Risk in Differentiated Vulvar Intraepithelial Neoplasia: A Systematic Review. Cancers (Basel). 2021 Dec 7;13(24):6170.
Judith J. Spekreijse, Bianca M.M. Streng, Ravi F.M. Vermeulen, Feline O. Voss, Hester Vermaat, Marc van Beurden. The risk of developing squamous cell carcinoma in patients with anogenital lichen sclerosis: A systematic review. Gynecol Oncol. 2020 Jun;157(3):671-677.
Ravi F.M. Vermeulen, Catharina M. Korse, Gemma G. Kenter, Monique M.A. Brood-van Zanten and Marc van Beurden. Safety of hormone replacement therapy following RRSO: systematic review of literature and guidelines. Climacteric. 2019 Aug;22(4):352-360.
Ravi F.M. Vermeulen, Marc van Beurden, Katja N. Gaarenstroom, Teun Teunis, Jacobien M. Kieffer, Neil K. Aaronson, Gemma G. Kenter, Catharina M. Korse. Does anti-Müllerian hormone predict change in menopausal symptoms following risk-reducing salpingo-oophorectomy? A prospective observational study. Climacteric. 2018 Dec;21(6):574-580.
Ravi F.M. Vermeulen, Marc van Beurden, Jacobien M. Kieffer, Eveline M.A. Bleiker, Heiddis B. Valdimarsdottir, Leon F.A.G. Massuger, Marian J.E. Mourits, Katja N. Gaarenstroom, Eleonora B.L. van Dorst, Hans W.H.M. van der Putten, Neil K. Aaronson. Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimizes endocrine and sexual problems: a prospective study. Eur J Cancer. 2017 Oct;84:159-167.
Ravi F.M. Vermeulen, Marc van Beurden, Catharina M. Korse, Gemma G. Kenter. The impact of risk-reducing salpingo-oophorectomy on physical and psychological health among premenopausal women, a systematic review. Climacteric, 2017 Jun;20(3):212-221.
